A study of complexes of class II invariant chain peptide: major histocompatibility complex class II molecules using a new complex-specific monoclonal antibody
- PMID: 8617308
- DOI: 10.1002/eji.1830260218
A study of complexes of class II invariant chain peptide: major histocompatibility complex class II molecules using a new complex-specific monoclonal antibody
Abstract
Complexes of major histocompatibility complex (MHC) class II molecules containing invariant chain (Ii)-derived peptides, known as class II-associated invariant chain peptides (CLIP), are expressed at high levels in presentation-deficient mutant cells. Expression of these complexes in mutant and wild-type antigen-presenting cells suggests that they represent an essential intermediate in the MHC class II antigen-presenting pathway. We have generated a monoclonal antibody, 30-2, which is specific for these complexes. Using this antibody, we have found quantitative differences in CLIP:MHC class II surface expression in mutant and wild-type cells. Our experiments also show that CLIP:MHC class II complexes are preferentially expressed on the cell surface similar to total mature MHC class II molecules. These complexes are found to accumulate in the endosomal compartment in the process of endosomal Ii degradation. Analysis of the fine specificity of the antibody indicates that these complexes have Li peptide bound to the peptide-binding groove.
Similar articles
-
Modulation of antigen presentation and class II expression by a class II-associated invariant chain peptide.J Immunol. 1996 Jun 1;156(11):4232-9. J Immunol. 1996. PMID: 8666792
-
T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates.J Exp Med. 1995 Nov 1;182(5):1403-13. doi: 10.1084/jem.182.5.1403. J Exp Med. 1995. PMID: 7595211 Free PMC article.
-
Differential expression of CLIP:MHC class II and conventional endogenous peptide:MHC class II complexes by thymic epithelial cells and peripheral antigen-presenting cells.Eur J Immunol. 1996 Dec;26(12):3185-93. doi: 10.1002/eji.1830261252. Eur J Immunol. 1996. PMID: 8977321
-
Ancient features of the MHC class II presentation pathway, and a model for the possible origin of MHC molecules.Immunogenetics. 2019 Mar;71(3):233-249. doi: 10.1007/s00251-018-1090-2. Epub 2018 Oct 30. Immunogenetics. 2019. PMID: 30377750 Review.
-
Structure of peptides associated with class I and class II MHC molecules.Annu Rev Immunol. 1994;12:181-207. doi: 10.1146/annurev.iy.12.040194.001145. Annu Rev Immunol. 1994. PMID: 7516668 Review.
Cited by
-
Monoclonal antibody blocking the recognition of an insulin peptide-MHC complex modulates type 1 diabetes.Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2656-61. doi: 10.1073/pnas.1323436111. Epub 2014 Feb 3. Proc Natl Acad Sci U S A. 2014. PMID: 24550292 Free PMC article.
-
TCR-like antibodies distinguish conformational and functional differences in two- versus four-domain auto reactive MHC class II-peptide complexes.Eur J Immunol. 2011 May;41(5):1465-79. doi: 10.1002/eji.201041241. Epub 2011 Apr 12. Eur J Immunol. 2011. PMID: 21469129 Free PMC article.
-
Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library.Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):7969-74. doi: 10.1073/pnas.97.14.7969. Proc Natl Acad Sci U S A. 2000. PMID: 10884427 Free PMC article.
-
Conformational changes within the HLA-A1:MAGE-A1 complex induced by binding of a recombinant antibody fragment with TCR-like specificity.Protein Sci. 2009 Jan;18(1):37-49. doi: 10.1002/pro.4. Protein Sci. 2009. PMID: 19177349 Free PMC article.
-
Prediction of the binding affinities of peptides to class II MHC using a regularized thermodynamic model.BMC Bioinformatics. 2010 Jan 20;11:41. doi: 10.1186/1471-2105-11-41. BMC Bioinformatics. 2010. PMID: 20089173 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials